Abstract

We evaluated plasma creatinine, urea, bilirubin, lactic acid, and nitric oxide values in children with malaria to identify indices of disease severity and predictors of fatal outcomes. Children 0 to 15 years old were recruited, clinical data recorded, and blood samples collected. Plasma creatinine, urea, bilirubin, lactic acid, and nitric oxide (NO) values were determined by spectrophotometry. Values of creatinine, urea, and bilirubin were normal in all the groups except for urea in some groups (55.30 +/- 5.508 mg/dL and 60.45 +/- 15.56 mg/dL in anemia patients and those with the combined symptoms of cerebral malaria and anemia, respectively). The mean lactate values were high in severe malaria groups (0.57 +/- 0.05 g/L and 0.48 +/- 0.05 g/L in cerebral malaria and anemia patients, respectively). As for the mean NO values, they were above the normal range in all the groups, except the controls, but particularly in the severe malaria groups (68.66 +/- 7.85, 84.52 +/- 8.17, 99.57 +/- 10.48, 87.25 +/- 12.57, and 93.48 +/- 7.09 micromol/L for the control, uncomplicated malaria, anemia, cerebral malaria patients and those with the combined symptoms of cerebral malaria and anemia, respectively; P = 0.643). In this setting, lactate and NO were indicators of poor prognosis. Though the impact of creatinine, urea, and bilirubin were not found to be significant, they can still be useful to assess improvement in severe malaria cases.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.